We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Saliva Tests Are as Accurate and Effective as Nasopharyngeal Tests in Precisely Diagnosing COVID-19, Finds Study

By HospiMedica International staff writers
Posted on 17 Feb 2021
Print article
Image: Allplex SARS-CoV-2 Assay (Photo courtesy of Seegene, Inc.)
Image: Allplex SARS-CoV-2 Assay (Photo courtesy of Seegene, Inc.)
A new study has shown that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.

A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine (Seoul, Korea) carried out the PCR test for COVID-19 on 90 hospitalized individuals with suspected COVID-19, both with saliva and nasopharyngeal methods. In order to collect sufficient specimen, samples were collected from study participants, who were required to refrain from any activities including eating, drinking, and smoking, for 30 minutes after they got up in the morning.

For the study, the research team had used Seegene, Inc.’s (Seoul, Korea) COVID-19 tests, the Allplex SARS-CoV-2 Assay and Allplex SARS-CoV-2/FluA/FluB/RSV Assay. While the Allplex SARS-CoV-2 Assay targets four different genes of COVID-19, the Allplex SARS-CoV-2/FluA/FluB/RSV Assay is known to detect and differentiate eight target genes, including COVID-19, influenza and RSV common cold.

As a result, both the Allplex SARS-CoV-2 Assay and Allplex SARS-CoV-2/FluA/FluB/RSV Assay proved the saliva and nasopharyngeal test's percentage agreement for detecting COVID-19 was over 98.8%. That means COVID-19 diagnostic tests give equally accurate and effective test results for COVID-19 when testing saliva and nasopharyngeal specimen.

The research team also conducted a separate study on extraction-free application, one without the nucleic acid extraction step, and found the percentage agreement between Seegene's extraction-free saliva test and extraction-free nasopharyngeal swab test to be over 96%. In other words, the extraction-free method using the saliva sampling would be just as applicable for the PCR test in detecting SARS-CoV-2.

"The demand for saliva-based COVID-19 tests is on the rise, as the world still battles with short supply of specimen collecting swab for nasopharyngeal tests," said Professor Suh, the lead researcher of the study, adding that the study has "clearly proven that saliva tests are just as accurate and effective as nasopharyngeal tests in precisely diagnosing COVID-19."

Related Links:
Kangwon National University School of Medicine
Seegene, Inc.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Forceps
BiClamp LAP

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.